NEJM Journal Watch » Oncology And Hematology
209 FOLLOWERS
NEJM Journal Watch features summaries of and commentary on oncology and hematology medical journal articles covering topics such as breast cancer, gastrointestinal cancer, malignant hematology, benign hematology, etc. Follow to get updates.
NEJM Journal Watch » Oncology And Hematology
5d ago
Alectinib improved disease-free survival compared with chemotherapy in patients with early stage, resected ALK+ NSCLC ..read more
NEJM Journal Watch » Oncology And Hematology
5d ago
Overall survival was significantly improved with pembrolizumab compared with placebo in the KEYNOTE-564 trial ..read more
NEJM Journal Watch » Oncology And Hematology
5d ago
In patients aged 70 and older with stage III colon cancer, time to recurrence was similar to that in younger patients ..read more
NEJM Journal Watch » Oncology And Hematology
1w ago
Higher levels of TILs were associated with greater survival in patients who did not receive chemotherapy ..read more
NEJM Journal Watch » Oncology And Hematology
1w ago
Survival was similar with and without completion axillary lymph node dissection in patients with clinically node-negative breast cancer and sentinel node metastases ..read more
NEJM Journal Watch » Oncology And Hematology
2w ago
The addition of pembrolizumab to standard chemoradiotherapy followed by pembrolizumab maintenance improved progression-free survival compared with chemoradiotherapy alone ..read more
NEJM Journal Watch » Oncology And Hematology
3w ago
Adding pembrolizumab to combined dabrafenib and trametinib shows a promising improvement in patients' overall survival in a retrospective, single-center study ..read more
NEJM Journal Watch » Oncology And Hematology
3w ago
Adding ribociclib to endocrine therapy improved invasive disease–free survival in a diverse group of patients with estrogen-receptor positive, HER2− cancer ..read more
NEJM Journal Watch » Oncology And Hematology
3w ago
Sensitivity and specificity were high, but a small proportion of patients assessed as low risk might deserve further testing ..read more
NEJM Journal Watch » Oncology And Hematology
3w ago
A new prediction model indicates which patients with MGUS should be considered for bone marrow sampling ..read more